Effect of two dosages of sodium chloride intake on the blood pressure response to caffeinated coffee in humans in vivo

References

• Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. 2013. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 346:f1326.
   PubMed Web of Science ®Google Scholar
• Carroll MA. 2012. Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertension. Prostaglandins Other Lipid Mediat. 98(3–4):39–47.
   PubMed Web of Science ®Google Scholar
• Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. 2007. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 334(7599):885–888.
   PubMed Web of Science ®Google Scholar
• Dobrowolski L, Kompanowska-Jezierska E, Walkowska A, Sadowski J. 2007. Sodium intake determines the role of adenosine A2 receptors in control of renal medullary perfusion in the rat. Nephrol Dial Transplant. 22(10):2805–2809.
   PubMed Web of Science ®Google Scholar
• Guessous I, Eap CB, Bochud M. 2014. Blood pressure in relation to coffee and caffeine consumption. Curr Hypertens Rep. 16(9):468.
   PubMed Web of Science ®Google Scholar
• He FJ, Li J, Macgregor GA. 2013. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 346:f1325.
   PubMed Web of Science ®Google Scholar
• He FJ, Markandu ND, Sagnella GA, MacGregor GA. 1998. Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension. 32(5):820–824.
   PubMed Web of Science ®Google Scholar
• Intersalt Cooperative Research Group. 1988. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 297(6644):319–328.
   PubMedGoogle Scholar
• Liclican EL, Doumad AB, Wang J, Li J, Falck JR, Stier CT Jr, Carroll MA. 2009. Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive. Hypertension. 54(6):1284–1290.
   PubMed Web of Science ®Google Scholar
• Liclican EL, McGiff JC, Pedraza PL, Ferreri NR, Falck JR, Carroll MA. 2005. Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids. Am J Physiol Renal Physiol. 289(2):F386–F392.
   PubMed Web of Science ®Google Scholar
• Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, Morrison H, Li W, Wang X, Di C, et al. 2014. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 371(7):601–611.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, Lim S, Danaei G, Ezzati M, Powles J. 2014. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 371(7):624–634.
   PubMed Web of Science ®Google Scholar
• Nayeem MA, Zeldin DC, Boegehold MA, Falck JR. 2011. Salt modulates vascular response through adenosine A(2A) receptor in eNOS-null mice: role of CYP450 epoxygenase and soluble epoxide hydrolase. Mol Cell Biochem. 350(1–2):101–111.
   PubMed Web of Science ®Google Scholar
• Nayeem MA, Zeldin DC, Boegehold MA, Morisseau C, Marowsky A, Ponnoth DS, Roush KP, Falck JR. 2010. Modulation by salt intake of the vascular response mediated through adenosine A(2A) receptor: role of CYP epoxygenase and soluble epoxide hydrolase. Am J Physiol Regul Integr Comp Physiol. 299(1):R325–R333.
   PubMed Web of Science ®Google Scholar
• Obarzanek E, Proschan MA, Vollmer WM, Moore TJ, Sacks FM, Appel LJ, Svetkey LP, Most-Windhauser MM, Cutler JA. 2003. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension. 42(4):459–467.
   PubMed Web of Science ®Google Scholar
• O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, Yan H, Lee SF, Mony P, Devanath A, et al. 2014. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 371(7):612–623.
   PubMed Web of Science ®Google Scholar
• Poucher SM, Keddie JR, Singh P, Stoggall SM, Caulkett PW, Jones G, Coll MG. 1995. The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br J Pharmacol. 115(6):1096–1102.
   PubMed Web of Science ®Google Scholar
• Riksen NP, Rongen GA, Smits P. 2009. Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther. 121(2):185–191.
   PubMed Web of Science ®Google Scholar
• Riksen NP, Smits P, Rongen GA. 2011. The cardiovascular effects of methylxanthines. Handb Exp Pharmacol. (200):413–437.
   PubMedGoogle Scholar
• Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, et al. 2001. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 344(1):3–10.
   PubMed Web of Science ®Google Scholar
• Schreiber-Deturmeny E, Bruguerolle B. 1996. Simultaneous high-performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma. J Chromatogr B, Biomed Appl. 677(2):305–312.
   PubMedGoogle Scholar
• Siragy HM, Linden J. 1996. Sodium intake markedly alters renal interstitial fluid adenosine. Hypertension. 27(3):404–407.
   PubMed Web of Science ®Google Scholar
• Smits P, Boekema P, Abreu RD, Thien T, Vanʼt Laar A. 1987. Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol. 10(2):136–143.
   PubMed Web of Science ®Google Scholar
• Smits P, Hoffmann H, Thien T, Houben H, van't Laar A. 1983. Hemodynamic and humoral effects of coffee after beta 1-selective and nonselective beta-blockade. Clin Pharmacol Ther. 34(2):153–158.
   PubMed Web of Science ®Google Scholar
• Smits P, Thien T, Van 't Laar A. 1985a. The cardiovascular effects of regular and decaffeinated coffee. Br J Clin Pharmacol. 19(6):852–854.
   PubMed Web of Science ®Google Scholar
• Smits P, Thien T, van't Laar A. 1985b. Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am J Cardiol. 56(15):958–963.
   PubMed Web of Science ®Google Scholar
• Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. 2009. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 339:b4567.
   PubMed Web of Science ®Google Scholar
• van Dusseldorp M, Smits P, Thien T, Katan MB. 1989. Effect of decaffeinated versus regular coffee on blood pressure. A 12-week, double-blind trial. Hypertension. 14(5):563–569.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Coca A, Casa DJ, Antonio J, Green JM, Bishop PA. 2015. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 18(5):569–574.
   PubMed Web of Science ®Google Scholar